| P2093 | author name string | Richard N Channick | |
| | Eugene Pomerantsev | |
| | Barbara L LeVarge | |
| P2860 | cites work | Pulmonary Hemodynamics in Obstructive Lung Disease | Q72022818 |
| | Interpretation of the pulmonary artery occlusion pressure in mechanically ventilated patients with large respiratory excursions in intrathoracic pressure | Q74063751 |
| | Expiratory flow limitation and intrinsic positive end-expiratory pressure in obesity | Q77369207 |
| | Bosentan therapy for pulmonary arterial hypertension | Q77801473 |
| | Physiological studies of the effects of intermittent positive pressure breathing on cardiac output in man | Q79551612 |
| | Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension | Q80199008 |
| | The influence of the respiration on the circulation in man; with special reference to pressures in the right auricle, right ventricle, femoral artery and peripheral veins | Q82188417 |
| | Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure | Q83412875 |
| | Atorvastatin in pulmonary arterial hypertension (APATH) study | Q83507595 |
| | Neural respiratory drive in obesity | Q83704736 |
| | Vardenafil in pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled study | Q83797946 |
| | Right atrial pressure affects the interaction between lung mechanics and right ventricular function in spontaneously breathing COPD patients | Q28732760 |
| | Updated clinical classification of pulmonary hypertension. | Q30378433 |
| | Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. | Q33147483 |
| | Inhaled iloprost for severe pulmonary hypertension | Q33147955 |
| | Respiratory restriction and elevated pleural and esophageal pressures in morbid obesity | Q33910809 |
| | Pulmonary arterial hypertension in France: results from a national registry | Q33993302 |
| | Sildenafil citrate therapy for pulmonary arterial hypertension | Q34562650 |
| | ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American Coll | Q34977467 |
| | Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In | Q34999923 |
| | RECORDING OF RIGHT HEART PRESSURES IN NORMAL SUBJECTS AND IN PATIENTS WITH CHRONIC PULMONARY DISEASE AND VARIOUS TYPES OF CARDIO-CIRCULATORY DISEASE. | Q35166658 |
| | THE CIRCULATORY EFFECTS OF ELECTRICALLY INDUCED CHANGES IN VENTRICULAR RATE AT REST AND DURING EXERCISE IN COMPLETE HEART BLOCK | Q35569114 |
| | Cardiovascular issues in respiratory care | Q36321447 |
| | Poor agreement between pulmonary capillary wedge pressure and left ventricular end-diastolic pressure in a veteran population | Q37538621 |
| | Variables in pulmonary capillary wedge pressure: variation with intrathoracic pressure, graphic and digital recorders. | Q39365183 |
| | Comparison of pulmonary artery and central venous pressure waveform measurements via digital and graphic measurement methods | Q39557343 |
| | Current practice for determining pulmonary capillary wedge pressure predisposes to serious errors in the classification of patients with pulmonary hypertension. | Q40031477 |
| | Influence of acetylcholine on the pulmonary arterial pressure | Q41281918 |
| | Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study | Q43764381 |
| | Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial | Q44240810 |
| | Demographics and outcomes of patients diagnosed with pulmonary hypertension with pulmonary capillary wedge pressures 16 to 18 mm Hg: insights from the REVEAL Registry. | Q44311032 |
| | Zero reference level for right heart catheterisation | Q44318410 |
| | A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension | Q44938984 |
| | Usefulness of pulmonary capillary wedge pressure as a correlate of left ventricular filling pressures in pulmonary arterial hypertension. | Q45039116 |
| | Pulmonary hypertension at exercise in COPD: does it matter? | Q45842305 |
| | Tadalafil therapy for pulmonary arterial hypertension. | Q45995795 |
| | Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. | Q48385253 |
| | A USA-based registry for pulmonary arterial hypertension: 1982-2006. | Q51739149 |
| | The effect of ventilation on the accuracy of pulmonary artery and wedge pressure measurements. | Q52704558 |
| | Analysis of observer variability in measurement of pulmonary artery occlusion pressures. | Q52914225 |
| | Measuring central pulmonary pressures during exercise in COPD: how to cope with respiratory effects. | Q53129111 |
| | Wedge pressure measurement in obstructive pulmonary disease. | Q53705138 |
| | Multidisciplinary treatment of chronic pulmonary insufficiency. 4. The influence of intrathoracic pressure variations on increases in pulmonary vascular pressure during exercise in patients with chronic obstructive pulmonary disease | Q67711237 |
| | Cause of the raised wedge pressure on exercise in chronic obstructive pulmonary disease | Q67976080 |
| | Temporary muscle paralysis for accurate measurement of pulmonary artery occlusion pressure | Q71065211 |
| P433 | issue | 2 | |
| P921 | main subject | misclassification | Q61793526 |
| P304 | page(s) | 425-434 | |
| P577 | publication date | 2014-06-12 | |
| P1433 | published in | European Respiratory Journal | Q12257435 |
| P1476 | title | Reliance on end-expiratory wedge pressure leads to misclassification of pulmonary hypertension | |
| P478 | volume | 44 | |